Impact of Single Antiplatelet, Dual Antiplatelet, and Anticoagulation Plus Antiplatelet Therapy on Branch Vessel Patency and Bleeding Risk Following Branched Endovascular Aortic Repair.

Lu, Y., Longbao, Z., Xiaoling, X., Juanping, Z., & Long, Y. (2026). Impact of Single Antiplatelet, Dual Antiplatelet, and Anticoagulation Plus Antiplatelet Therapy on Branch Vessel Patency and Bleeding Risk Following Branched Endovascular Aortic Repair.. Cardiovascular drugs and therapy.

Lu Y, Longbao Z, Xiaoling X, Juanping Z, Long Y. Impact of Single Antiplatelet, Dual Antiplatelet, and Anticoagulation Plus Antiplatelet Therapy on Branch Vessel Patency and Bleeding Risk Following Branched Endovascular Aortic Repair.. Cardiovascular drugs and therapy. 2026; PMID: 42068529

Lu Y, Longbao Z, Xiaoling X, et al. Impact of Single Antiplatelet, Dual Antiplatelet, and Anticoagulation Plus Antiplatelet Therapy on Branch Vessel Patency and Bleeding Risk Following Branched Endovascular Aortic Repair.[J]. Cardiovascular drugs and therapy. 2026.

@article{lu2026,
  author = {Ye Lu and Zhao Longbao and Xie Xiaoling and Zhang Juanping and Yang Long},
  title = {Impact of Single Antiplatelet, Dual Antiplatelet, and Anticoagulation Plus Antiplatelet Therapy on Branch Vessel Patency and Bleeding Risk Following Branched Endovascular Aortic Repair.},
  journal = {Cardiovascular drugs and therapy},
  year = {2026},
  note = {PMID: 42068529},
}

TY  - JOUR
AU  - Ye Lu
AU  - Zhao Longbao
AU  - Xie Xiaoling
AU  - Zhang Juanping
AU  - Yang Long
TI  - Impact of Single Antiplatelet, Dual Antiplatelet, and Anticoagulation Plus Antiplatelet Therapy on Branch Vessel Patency and Bleeding Risk Following Branched Endovascular Aortic Repair.
T2  - Cardiovascular drugs and therapy
PY  - 2026
AN  - PMID:42068529
ER  -